本文首发于公众号"私募排排网"。 （点击↑↑ 上图查看详情 ） 今年以来，A股继续迎来强劲的上涨，其中沪指创下近十年新高；创业板指年内最新涨幅达到约45%，领衔A股三大主要股指。板块方面，近 日，以算力为核心的新科技板块，俨然成为撬动指数上涨的主引擎。在此基础上，不少近5年才成立的新锐私募崭露头角，成为私募市场上一股 重要的力量。 （注：本文业绩数据截至2025年9月12日，近5年成立的新锐私募即2020年9月12日后成立的私募） 0 1 私募公司：北京禧悦夺冠！量化私募巨量均衡进入 从私募公司的角度看，近5年成立的新锐私募共有1056家，其中今年来至少有3只产品符合排名规则的私募共有60家，收益20强的公司的上榜"门 槛"为 *** %。（ 点此查看收益 ） [应监管要求，私募基金不能公开展示业绩，文中涉及收益数据用***替代，合格投资者可扫描图中二维码或点击文末阅读原文，查看收益数据。] 在这20家私募中，主观私募共有12家，量化私募、混合型（"主观+量化"）私募各有4家。从公司规模来看，这20家私募的管理规模均不足50 亿。 10 强 | 排名 | 公司简称 | 实控人 | | 公司规模 投资模式 核心 ...

Core Viewpoint - The A-share market showed strong performance in August, with major indices rising significantly, yet the excess returns of stock strategy private equity products were disappointing, marking the worst monthly performance of the year [1][2]. Group 1: Market Performance - In August, the Shanghai Composite Index rose by 7.97%, the Shenzhen Component Index increased by 15.32%, and the ChiNext Index surged over 24% [1]. - Despite the strong market, the average excess return of 3,122 stock strategy private equity products was -1.97%, the worst monthly performance this year [1]. Group 2: Quantitative vs. Subjective Strategies - Quantitative private equity products experienced a notable decline, with an average excess return of -3.94% in August, while subjective private equity products had an average excess return of -1.00% [1]. - The significant decline in quantitative products is attributed to a reversal in style, particularly the outperformance of large-cap stocks over small-cap stocks, and severe sector differentiation due to rapid growth in financing scale [1][2]. Group 3: Consistent Performers - As of August 2025, only 95 stock strategy private equity products achieved positive excess returns for eight consecutive months, representing about 3% of the total [2]. - Among private equity firms with over 10 billion in assets, 46 products achieved positive excess returns for eight consecutive months, all of which were quantitative products, with an average excess return of 0.63% in August and 17.91% year-to-date [3]. Group 4: Top Performers by Asset Size - In the 20-100 billion category, 14 products achieved positive excess returns for eight consecutive months, with an average excess return of 1.83% in August and 22.48% year-to-date [7]. - The top three products in this category were "New Thinking Multi-Strategy 3", "Pansong Micro-Cap Index Enhanced 1", and "Giraffe 7", with year-to-date excess returns of ***% [11]. Group 5: Small and Emerging Firms - In the 5-20 billion category, 13 products achieved positive excess returns for eight consecutive months, with an average excess return of 5.34% in August and 57.58% year-to-date [13]. - The leading product in the 0-5 billion category was "Zijin Yunsong", achieving a year-to-date excess return of ***% [18].

Core Viewpoint - The article highlights the performance of private equity funds in the range of 5-10 billion, indicating a strong average return of 24.25% year-to-date, with stock strategy products significantly outperforming the market [1][2]. Group 1: Performance Overview - There are 570 products under private equity funds with performance data, totaling approximately 951.82 billion yuan, with an average return of 24.25% this year [1][2]. - Stock strategy products, totaling 470, have an average return of 26.58%, outperforming the market significantly [1][2]. - Futures and derivatives strategy products have lagged behind, with only 25 products showing an average return of 6.04% this year [1][2]. Group 2: Strategy Breakdown - The performance of various strategies is as follows: - Stock Strategy: 470 products, 7,909,036.93 million yuan, 8-month return of 6.23%, year-to-date return of 26.58% [2]. - Multi-Asset Strategy: 79 products, 1,083,120.75 million yuan, 8-month return of 5.79%, year-to-date return of 17.97% [2]. - Futures and Derivatives Strategy: 25 products, 241,368.31 million yuan, 8-month return of 1.24%, year-to-date return of 6.04% [2]. - Bond Strategy: 17 products, 228,625.42 million yuan, 8-month return of 1.32%, year-to-date return of 5.66% [2]. - Combination Fund: 3 products, 56,001.36 million yuan, 8-month return of 9.33%, year-to-date return of 31.87% [2]. Group 3: Quantitative Strategy Performance - There are 76 quantitative long products with an average return of 36.30% year-to-date, outperforming the average [3][4]. - The top three quantitative long products for the year are from Pansong Asset, Beiyang Quantitative, and Zhengying Asset [4]. Group 4: Subjective Long Strategy Performance - 82 subjective long products have an average return of 30.86% year-to-date, benefiting from a strong equity market [7][8]. - The top three subjective long products are from Yuanxin Investment, Tongben Investment, and Kangmand Capital [8]. Group 5: Market Neutral Strategy Performance - 37 market-neutral products have an average return of 6.53% year-to-date, with the top three products from Pansong Investment, Liangkui Private Equity, and Pansong Asset [11][12]. Group 6: Multi-Asset Strategy Performance - 79 multi-asset strategy products have an average return of 14.51% year-to-date, with the top three products from Guoyuan Xinda, Luoshu Investment, and Chanlong Asset [13][14]. Group 7: Futures and Derivatives Strategy Performance - 52 futures and derivatives strategy products have an average return of 8.92% year-to-date, with the top three products from Hongxi Fund, Luoshu Investment, and Jiahong Fund [15][16].

Core Viewpoint - The stock market experienced a broad rally in August, but there was significant divergence among individual stocks, leading to a general decline in excess returns for quantitative strategies. Only 20.83% of the 696 quantitative long products achieved positive excess returns in August [2][3]. Summary by Sections Market Performance - In August, the quantitative long strategies saw a decline in excess returns, particularly after the second week, when technology stocks like Yizhongtian, Hanwujing, and Industrial Fulian became the main drivers of market gains, while other sectors lagged [2][3]. - The average excess return for quantitative long products was -2.28% for the month, with only 145 out of 696 products achieving positive excess returns [3]. Weekly Performance Breakdown - **Week 1**: Average excess return of 0.81%, with 84.20% of products achieving positive excess [3]. - **Week 2**: Average excess return of -1.06%, with only 21.98% of products achieving positive excess [3]. - **Week 3**: Average excess return of -0.61%, with 23.85% of products achieving positive excess [3]. - **Week 4**: Average excess return of -1.99%, with only 12.21% of products achieving positive excess [3]. Notable Products - Despite the overall decline, 20 products managed to achieve positive excess returns for all four weeks in August, including "Mingyue Songjian Zhaozhao 1" managed by Huang Chen and "Nianjue Lianzhen Quantitative Selected Excellent 1" managed by Wang Xiao [3][4]. - The top-performing product in August was "Nianjue Lianzhen Quantitative Selected Excellent 1," which achieved a significant excess return, outperforming other quantitative long products [9]. Performance by Fund Size - **Over 100 Billion**: 51 products achieved positive excess returns, with a total excess return of -1.69% [5][10]. - **50-100 Billion**: 20 products achieved positive excess returns, with a total excess return of -1.35% [10][11]. - **20-50 Billion**: 9 products achieved positive excess returns, with a total excess return of -2.53% [13]. - **10-20 Billion**: 14 products achieved positive excess returns, with a total excess return of -2.57% [16]. - **5-10 Billion**: 19 products achieved positive excess returns, with a total excess return of -2.55% [18]. - **0-5 Billion**: 32 products achieved positive excess returns, with a total excess return of -3.02% [20]. Key Players - Mingyue Songjian Zhaozhao 1 and Nianjue Lianzhen Quantitative Selected Excellent 1 were highlighted for their strong performance in August [4][9]. - Mingyue Investment and Mengxi Investment were noted for their significant number of products achieving positive excess returns [8][9].

Core Viewpoint - The introduction of the CSI 2000 Index reflects the increasing representation of small and medium-sized companies in the A-share market, showcasing strong long-term performance with a cumulative return of 166.50% since its base date, outperforming major broad-based indices [2][3]. Group 1: Characteristics of the CSI 2000 Index - The CSI 2000 Index uniquely focuses on small and micro-cap stocks, comprising 2000 stocks with smaller market capitalizations and better liquidity, effectively complementing other indices like CSI 300 and CSI 500 [7]. - The index covers 30 primary industries, with high-growth sectors such as machinery, electronics, basic chemicals, and pharmaceuticals accounting for nearly 40% of its composition, indicating a diversified and growth-oriented portfolio [9]. - The index exhibits high elasticity and volatility, making it attractive to investors with a higher risk appetite, especially in a macro environment characterized by loose liquidity [11]. Group 2: Investment Strategies and Opportunities - The CSI 2000 Index is well-suited for quantitative strategies due to its lower analyst coverage, allowing for the identification of undervalued stocks and pricing inefficiencies, which can lead to excess returns [19]. - The high trading activity and turnover rates of the CSI 2000 Index enhance the effectiveness of quantitative trading strategies, enabling better monitoring of market dynamics and execution of trades [18]. - The index's broad selection of constituent stocks provides greater freedom in stock selection, allowing for the application of various alpha factors and reducing exposure risks associated with non-index stocks [17].